Richard A. Paulson Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Richard A. Paulson is President and CEO of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 84,046 shares of KPTI, which is worth approximately $526,127. The most recent transaction as insider was on Nov 06, 2023, when has been sold 3,606 shares (Common Stock) at a price of $0.92 per share, resulting in proceeds of $3,317. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84K

1.87% 3M change

92.62% 12M change

Total Value Held $526,127

Richard A. Paulson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2023	SELL Open market or private sale	$3,317 $0.92 p/Share	3,606 Reduced 0.45%	791,201 Common Stock
Oct 04 2023	SELL Open market or private sale	$4,558 $1.27 p/Share	3,589 Reduced 0.45%	794,807 Common Stock
Sep 05 2023	SELL Open market or private sale	$4,817 $1.33 p/Share	3,622 Reduced 0.45%	798,396 Common Stock
Aug 07 2023	SELL Open market or private sale	$6,401 $1.72 p/Share	3,722 Reduced 0.46%	802,018 Common Stock
Jul 05 2023	SELL Open market or private sale	$6,085 $1.72 p/Share	3,538 Reduced 0.44%	805,740 Common Stock
Jun 05 2023	SELL Open market or private sale	$7,920 $2.24 p/Share	3,536 Reduced 0.44%	809,278 Common Stock
May 04 2023	SELL Open market or private sale	$12,746 $3.35 p/Share	3,805 Reduced 0.47%	812,814 Common Stock
Apr 04 2023	SELL Open market or private sale	$13,883 $3.97 p/Share	3,497 Reduced 0.43%	816,619 Common Stock
Mar 06 2023	SELL Open market or private sale	$11,078 $3.16 p/Share	3,506 Reduced 0.43%	820,116 Common Stock
Mar 01 2023	SELL Open market or private sale	$100,089 $3.03 p/Share	33,033 Reduced 3.86%	823,622 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	252,000 Added 22.73%	856,655 Common Stock
Feb 06 2023	SELL Open market or private sale	$13,430 $3.4 p/Share	3,950 Reduced 0.65%	604,655 Common Stock
Jan 04 2023	SELL Open market or private sale	$12,824 $3.27 p/Share	3,922 Reduced 0.64%	608,605 Common Stock
Dec 05 2022	SELL Open market or private sale	$18,043 $5.17 p/Share	3,490 Reduced 0.57%	612,527 Common Stock
Nov 04 2022	SELL Open market or private sale	$15,858 $4.54 p/Share	3,493 Reduced 0.56%	616,017 Common Stock
Oct 04 2022	SELL Open market or private sale	$20,475 $5.87 p/Share	3,488 Reduced 0.56%	619,510 Common Stock
Sep 08 2022	SELL Open market or private sale	$18,265 $5.25 p/Share	3,479 Reduced 0.56%	622,998 Common Stock
Aug 04 2022	SELL Open market or private sale	$10,367 $4.48 p/Share	2,314 Reduced 0.37%	626,477 Common Stock
Jul 08 2022	SELL Open market or private sale	$10,956 $5.18 p/Share	2,115 Reduced 0.34%	628,791 Common Stock
Jun 07 2022	SELL Open market or private sale	$14,642 $5.76 p/Share	2,542 Reduced 0.4%	630,906 Common Stock
May 04 2022	SELL Open market or private sale	$178,138 $6.25 p/Share	28,502 Reduced 4.31%	633,448 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	288,750 Added 30.37%	661,950 Common Stock
May 03 2021	BUY Grant, award, or other acquisition	-	373,200 Added 50.0%	373,200 Common Stock

Also insider at

BLUE

bluebird bio, Inc. Healthcare

RAP